Tff Pharmaceuticals Inc
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voricona… Read more
Market Cap & Net Worth: Tff Pharmaceuticals Inc (TFFP)
Tff Pharmaceuticals Inc (NASDAQ:TFFP) has a market capitalization of $288.80K ($288.80K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #39660 globally and #12906 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tff Pharmaceuticals Inc's stock price $0.07 by its total outstanding shares 4443040 (4.44 Million).
Tff Pharmaceuticals Inc Market Cap History: 2019 to 2025
Tff Pharmaceuticals Inc's market capitalization history from 2019 to 2025. Data shows change from $594.26 Million to $288.80K (-75.85% CAGR).
Tff Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tff Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
42.50x
Tff Pharmaceuticals Inc's market cap is 42.50 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $985.24 Million | $88.16 | -$30.99 Million | 11175636.57x | N/A |
| 2023 | $31.19 Million | $733.87K | -$21.24 Million | 42.50x | N/A |
Competitor Companies of TFFP by Market Capitalization
Companies near Tff Pharmaceuticals Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Tff Pharmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Tff Pharmaceuticals Inc Historical Marketcap From 2019 to 2025
Between 2019 and today, Tff Pharmaceuticals Inc's market cap moved from $594.26 Million to $ 288.80K, with a yearly change of -75.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $288.80K | 0.00% |
| 2024 | $288.80K | -99.07% |
| 2023 | $31.19 Million | -73.26% |
| 2022 | $116.63 Million | -88.16% |
| 2021 | $985.24 Million | -38.06% |
| 2020 | $1.59 Billion | +167.66% |
| 2019 | $594.26 Million | -- |
End of Day Market Cap According to Different Sources
On Feb 20th, 2026 the market cap of Tff Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $288.80K USD |
| MoneyControl | $288.80K USD |
| MarketWatch | $288.80K USD |
| marketcap.company | $288.80K USD |
| Reuters | $288.80K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.